Showing 421 - 440 results of 116,331 for search '(( a non decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.85s Refine Results
  1. 421
  2. 422

    MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure. by María Fernanda Podestá (639243)

    Published 2014
    “…MAP-2 and PSA-NCAM immunoreactive areas are expressed as mean values (±SEM) of 20–30 neurons per experimental condition. ns, non-significant; *** P<0.001 between bars, non-parametric Mann-Whitney test. …”
  3. 423
  4. 424
  5. 425

    Androgen and staurosporine synergize to decrease the relative ATP concentration in HPr-1AR cells. by Congcong Chen (796149)

    Published 2016
    “…In comparison to vehicle control, STS and to a lesser extent DHT significantly decrease the relative ATP concentration of HPr-1AR cells at 24 hours. …”
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433

    Rab7A decreases BST2 cell surface expression and is required for Vpu-induced BST2 cell surface downregulation. by Marina Caillet (198168)

    Published 2011
    “…<p>(<b>A</b>–<b>B</b>) Rab7A decreases BST2 cell surface expression. …”
  14. 434

    Decreased brain glucose uptake and glucose transporter expressions at early stage of female aging. by Fan Ding (302565)

    Published 2013
    “…<p>A. Representative FDG-microPET images showed an age-related decline in brain glucose uptake in nonTg brain, which was maximal between 6 and 9 months of age. …”
  15. 435
  16. 436

    Aged blood factors decrease cellular responses associated with delayed gingival wound repair by María Paz Saldías (4430032)

    Published 2017
    “…<div><p>Aging is a gradual biological process characterized by a decrease in cell and organism functions. …”
  17. 437

    Decreased thrombin activity levels in PAR KO following 24 hours following ischemia. by Efrat Shavit-Stein (3186678)

    Published 2021
    “…<p>(A) Total thrombin activity is significantly decreased in PAR1 KO compared to WT mice (t-test). …”
  18. 438
  19. 439

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  20. 440